Vultaggio Vincent
SEC CIK 2018766 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Principal Accounting Off | 153.4K | — | $115.0K | 5 | 2024-10-04 | 2026-02-06 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-10 | 2026-02-06+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO, PFO | S - Sale | $2.42 | -40.2K | 153.4K | -21% | -$97.5K |
| M | 2026-02-04 | 2026-02-02+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO, PFO | S - Sale | $2.54 | -3,096 | 187.3K | -2% | -$7,878 |
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO, Interim PFO | A - Grant | $0.00 | +158.6K | 192.4K | +468% | $0 |
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO, Interim PFO | S - Sale | $1.71 | -2,615 | 189.8K | -1% | -$4,472 |
| 2024-10-04 | 2024-10-04 | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | Principal Accounting Off | S - Sale | $3.18 | -1,603 | 33.9K | -5% | -$5,098 |
Purchase Sale Sale after option exercise All abbreviations